These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10197891)

  • 1. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment.
    Srisurapanont M; Jarusuraisin N; Jittiwutikan J
    Aust N Z J Psychiatry; 1999 Feb; 33(1):94-8. PubMed ID: 10197891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amineptine in the treatment of amphetamine withdrawal: a placebo-controlled, randomised, double-blind study.
    Jittiwutikan J; Srisurapanont M; Jarusuraisin N
    J Med Assoc Thai; 1997 Sep; 80(9):587-92. PubMed ID: 9347672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for amphetamine withdrawal.
    Shoptaw SJ; Kao U; Heinzerling K; Ling W
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003021. PubMed ID: 19370579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for amphetamine withdrawal.
    Srisurapanont M; Jarusuraisin N; Kittirattanapaiboon P
    Cochrane Database Syst Rev; 2001; (4):CD003021. PubMed ID: 11687170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure.
    Srisurapanont M; Jarusuraisin N; Jittiwutikan J
    Aust N Z J Psychiatry; 1999 Feb; 33(1):89-93. PubMed ID: 10197890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of amineptine in the treatment of depressive patients with irritable bowel syndrome.
    Alevizos B; Christodoulou GN; Ioannidis C; Voulgari A; Mantidis A; Spiliadis C
    Clin Neuropharmacol; 1989; 12 Suppl 2():S66-76. PubMed ID: 2698273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial.
    Thompson RG; Oliveto A; Thostenson JD; Wilson MP; McGaugh J; Mancino MJ
    J Psychopharmacol; 2021 Nov; 35(11):1420-1430. PubMed ID: 34697965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amphetamine in the rat.
    Samanin R; Jori A; Bernasconi S; Morpugo E; Garattini S
    J Pharm Pharmacol; 1977 Sep; 29(9):555-8. PubMed ID: 21261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind trial of amineptine and clomipramine in the treatment of depression.
    Lemoine P; Achaintre A; Balvay G; Bonnet H; Burgat R; Carrier C; Perrin J
    Curr Med Res Opin; 1981; 7(4):234-40. PubMed ID: 7014104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind clinical trial of the antidepressant action of amineptine.
    van Amerongen P
    Curr Med Res Opin; 1979; 6(2):93-100. PubMed ID: 380915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amineptine and amotival syndrome (author's transl)].
    Deniker P; Lôo H; Zarifian E; Peron P; Benyacoub A; Roux JM; Kamoun A
    Encephale; 1981; 7(1):59-64. PubMed ID: 7227285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression].
    Dalery J; Rochat C; Peyron E; Bernard G
    Encephale; 1992; 18(3):257-62. PubMed ID: 1299597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.
    Ferreri M
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():97-101. PubMed ID: 2644344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
    Jayaram-Lindström N; Hammarberg A; Beck O; Franck J
    Am J Psychiatry; 2008 Nov; 165(11):1442-8. PubMed ID: 18765480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
    Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
    Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
    Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
    Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of amineptine in the prevention of relapse in unipolar depression.
    Ferreri M; Colonna L; Leger JM
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S39-45. PubMed ID: 9347392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.